BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27249595)

  • 21. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma.
    Saarelainen SK; Peltonen N; Lehtimäki T; Perheentupa A; Vuento MH; Mäenpää JU
    Am J Obstet Gynecol; 2013 Aug; 209(2):142.e1-6. PubMed ID: 23583212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma.
    Quan Q; Liao Q; Yin W; Zhou S; Gong S; Mu X
    Sci Rep; 2021 Nov; 11(1):21694. PubMed ID: 34737393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of HE4 for ovarian cancer: a meta-analysis.
    Yu S; Yang HJ; Xie SQ; Bao YX
    Clin Chem Lab Med; 2012 Feb; 50(8):1439-46. PubMed ID: 22868811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
    Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A
    Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of the diagnostic accuracy of HE4 for endometrial carcinoma.
    Liu J; Han L; Sun Q; Li Y; Niyazi M
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():404-411. PubMed ID: 32711295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis.
    Kadija S; Stefanovic A; Jeremic K; Radojevic MM; Nikolic L; Markovic I; Atanackovic J
    Int J Gynecol Cancer; 2012 Feb; 22(2):238-44. PubMed ID: 22214964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research on application value of combined detection of serum CA125, HE4 and TK1 in the diagnosis of ovarian cancer.
    Xi QP; Pu DH; Lu WN
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4536-4541. PubMed ID: 29131263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis.
    Wu L; Dai ZY; Qian YH; Shi Y; Liu FJ; Yang C
    Int J Gynecol Cancer; 2012 Sep; 22(7):1106-12. PubMed ID: 22854652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital.
    Prueksaritanond N; Cheanpracha P; Yanaranop M
    Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
    Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer.
    Zhong W; Liu Y; Zhang L; Zhuang W; Chen J; Huang Z; Zheng Y; Huang Y
    PeerJ; 2023; 11():e16424. PubMed ID: 38077439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
    Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
    Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.
    Wang Y; Han C; Teng F; Bai Z; Tian W; Xue F
    Int J Gynaecol Obstet; 2017 Jan; 136(1):58-63. PubMed ID: 28099710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
    Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic value of serum human epididymis protein 4 in patients with primary fallopian tube carcinoma.
    Mi D; Zhang YX; Wang CJ; Feng Q; Qi P; Chen SQ
    J Obstet Gynaecol Res; 2016 Oct; 42(10):1326-1335. PubMed ID: 27307153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis.
    Bie Y; Zhang Z
    World J Surg Oncol; 2014 May; 12():169. PubMed ID: 24885319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic accuracy of HE4 in lung cancer: a meta-analysis.
    Cheng D; Sun Y; He H
    Dis Markers; 2015; 2015():352670. PubMed ID: 25873748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
    Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
    Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
    Zhang AM; Zhang P
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
    Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
    Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.